Omega Healthcare Investors (OHI) Cash & Equivalents (2009 - 2026)

Omega Healthcare Investors has reported Cash & Equivalents for 18 years, with the latest figure at $145.2 million in Q2 2026.

• Quarterly Cash & Equivalents fell 80.23% year-over-year to $145.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $145.2 million (down 80.23% YoY) and the FY2025 annual result came in at $27.5 million, down 94.69% from the prior year.
• Cash & Equivalents climbed to $145.2 million in Q2 2026 per OHI's latest filing, from $27.2 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $737.2 million in Q3 2025 and troughed at $5.4 million in Q2 2022.
• A 5-year average of $305.0 million and a median of $323.9 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents jumped 6394.28% in 2023, then tumbled 97.47% in 2024.
• Over 5 years, Cash & Equivalents stood at $297.1 million in 2022, then surged by 49.04% to $442.8 million in 2023, then gained by 17.06% to $518.3 million in 2024, then tumbled by 94.69% to $27.5 million in 2025, then jumped by 427.15% to $145.2 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $145.2 million, $27.2 million, and $27.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.